CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND)
SRF seeks to assist those suffering from Epidermolysis Bullosa ("EB"), in particular but not exclusively by making grants:(1) to fund medical research and/or clinical trials anywhere in the world for the purpose of discovering, developing and delivering treatments for EB; and(2) to fund the treatment of patients who are suffering from EB.
Financial health, per its FY2024 accounts
The accounts state that unrestricted reserves were £235,377 at year-end, while total net assets stood at £5,125,552. The trustees report that reserves substantially exceeded commitments, mitigating the principal risk of fundraising insufficiency. The charity maintains a low-cost operating base and does not require a significant unrestricted reserve fund to meet operating costs.
What the accounts disclose
“During the year the Charity introduced £638,664 (2023: £50,000) of support to its subsidiary EBTherapeutics Ltd.” — page 28
Leadership, per the charity’s website
- Sharmila — Founder and Trustee
Funders the charity credits
- Goldman Sachs Gives
- Redburn
Structured financials (annual return, FY ending 31/12/2024)
Register events
- Received assets from another charity (08/12/2021)
Trustees
- Duncan Wales
- JAMES DOUGLAS COLLINS
- MICHAEL GEORGES DE LATHAUWER
- PROFESSOR DAVID KELSELL
- Rachel Lesiter
- SHARMILA VIJAYANTHI NIKAPOTA
- TAZIM HALL
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £4.9m | £1.4m |
| 31/12/2023 | £731k | £1.6m |
| 31/12/2022 | £1.0m | £1.1m |
| 31/12/2021 | £1.6m | £859k |
| 31/12/2020 | £797k | £760k |
Common questions
Is CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND) financially healthy?
Per its FY2024 accounts: The accounts state that unrestricted reserves were £235,377 at year-end, while total net assets stood at £5,125,552. The trustees report that reserves substantially exceeded commitments, mitigating the principal risk of fundraising insufficiency. The charity maintains a low-cost operating base and does not require a significant unrestricted reserve fund to meet operating costs. Its FY2024 accounts were audited by Mitchell Charlesworth (Audit) Limited.
Who funds CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND)?
Funders whose own accounts filings name CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND) as a grant recipient include THE REED FOUNDATION.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE REED FOUNDATION | FY2022 | £11k | Christmas Challenge |
| THE REED FOUNDATION | FY2021 | — |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE SANDHU CHARITABLE FOUNDATION | 2 | £189k |
| ROBERT LUFF FOUNDATION LIMITED | 2 | £125k |
| SIR SAMUEL SCOTT OF YEWS TRUST | 2 | £25k |
| PILKINGTON CHARITIES FUND | 2 | £10k |
| THE FRANK LITCHFIELD GENERAL CHARITABLE TRUST | 2 | £5k |
| THE ASTOR FOUNDATION | 2 | £2k |
| The Squire Patton Boggs Charitable Trust | 2 | £750 |
| ARMED FORCES COVENANT FUND | 1 | £300k |
Charities like this
- DEBRA
- THE EHLERS-DANLOS SUPPORT UK
- THE SCAR FREE FOUNDATION
- PTEN RESEARCH FOUNDATION
- SIGHT RESEARCH UK
- THE NICHOLLS SPINAL INJURY FOUNDATION
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND) | £4.9m | — | 0 | unclear | — | no doubt |
| DEBRA | £18.2m | £130,001 - £140,000 | — | above | — | no doubt |
| THE EHLERS-DANLOS SUPPORT UK | £435k | — | 0 | below | — | no doubt |
| THE SCAR FREE FOUNDATION | £493k | — | — | above | — | noted |
| PTEN RESEARCH FOUNDATION | £716k | £180,001 - £190,000 | — | unclear | — | no doubt |
| SIGHT RESEARCH UK | £871k | — | 0 | below | — | no doubt |